Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

A new study suggests that men with inflammatory bowel disease (IBD) may face a significantly higher risk of developing heart disease over time.

Severe abdominal pains, unpredictable bowel movements and fatigue are some of the serious symptoms 180,000 Australians live ...

College of New Caledonia (CNC) has awarded a $5,000 scholarship to first-year nursing baccalaureate student Wynne Fitzpatrick ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...

The Levy family is excited to be recognized as the 2025 New England Take Steps Honored Family, and Soliel as the Honored Hero ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing ...

Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.